| · P-18 Need an endpoint for a clinical trial? Just ask L Harrelson-Woodlief, S Karnash, H Cohen, K Lee, E Topol, R Califf Controlled Clinical Trials 11 (4), 284, 1990 | 1 | 1990 |
| 'De bloem van het leven (la fleur de la vie)'. Bibliografie van Hugo Bousset (met inleiding) M Sergier, S Vanasten | | 2014 |
| & Fullerton, HJ (2014) AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha Heart disease and stroke statistics-2014 update. Circulation 129 (3), 143-152, 0 | 6 | |
| 1 0 Primary Angioplasty SJ Bremer, EJ Topol Management of Acute Coronary Syndromes, 281, 2002 | | 2002 |
| 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial SG Ellis, M Tendera, MA de Belder, AJ van Boven, P Widimsky, ... JACC: Cardiovascular Interventions 2 (10), 909-916, 2009 | 69 | 2009 |
| 1: Kern KB, Sasaoka T, Higashi H, Hilwig RW, Berg RA, Zuercher M. Post-resuscitation myocardial microcirculatory dysfunction is ameliorated with eptifibatide. Resuscitation … M Davidian, D Zhang, WJ Cantor, MH Sketch Jr, EM Ohman, JP Zidar, ... Resuscitation 81 (2), 255-9, 2010 | | 2010 |
| 1017-68 Influence of Platelet GP IIb/IIIa Receptor Inhibition with c7E3 on the Sequelae of Dissection During Percutaneous Coronary Revascularization AM Lincoff, EJ Topol, RM Califf, HF Weisman, NM Wildermann, SG Ellis Journal of the American College of Cardiology 25 (2 Supplement 1), 390A-391A, 1995 | 4 | 1995 |
| 1018-46 Influence of Randomized Trials on Clinical Practice: A Comparison of Directional Atherectomy and New Device Use Before and After the CAVEAT Trial at CAVEAT Sites N Omoigui, MJ Silver, L Rybicki, M Rosenthal, M Califf, EJ Topol, ... Journal of the American College of Cardiology 25 (2 Supplement 1), 393A, 1995 | 2 | 1995 |
| 1032-116 High Marginal Costs Associated with Routine Placement of Coronary Stents MJ Eisenberg, EJ Topol Journal of the American College of Cardiology 25 (2 Supplement 1), 418A, 1995 | | 1995 |
| 1043-66 Procedural predictors of creatine kinase-MB elevations in the REPLACE-2 study K Gavlick, JC Blankenship, NS Kleiman, JA Bittl, F Feit, EJ Topol, ... Journal of the American College of Cardiology 5 (43), A44, 2004 | 1 | 2004 |
| 1060-80 Female sex: A more important prognostic marker than treatment assignment or comorbid conditions among patients with acute myocardial infarction in the GUSTO V trial HR Reynolds, ME Farkouh, E Swahn, JA White, ZP Sadowski, AM Lincoff, ... Journal of the American College of Cardiology 5 (43), A261, 2004 | 1 | 2004 |
| 1063-54 Long-term clopidogrel therapy is particularly beneficial for patients requiring repeat revascularization after an initial percutaneous coronary intervention J Saw, EJ Topol, SR Steinhubl, D Brennan, PB Berger, DJ Moliterno Journal of the American College of Cardiology 5 (43), A50, 2004 | | 2004 |
| 1100-59 High-dose clopidogrel loading rapidly reduces both platelet inflammatory marker expression and aggregation FJ Zidar, DJ Moliterno, DL Bhatt, K Kottke-Marchant, M Goormastic, ... Journal of the American College of Cardiology 5 (43), A64, 2004 | 15 | 2004 |
| 1116-6 Long-term clopidogrel therapy following percutaneous coronary intervention improves clinical outcome but is not associated with increased bleeding: New insights from the … HD Aronow, SR Steinhubl, DM Brennan, EJ Topol Journal of the American College of Cardiology 5 (43), A21, 2004 | 2 | 2004 |
| 1120-65 Emboli protection improves thrombolysis in myocardial infarction perfusion score in saphenous vein graft intervention JE Exaire, C Haery, DL Bhatt, SJ Brener, SG Ellis, JS Yadar, EJ Topol Journal of the American College of Cardiology 5 (43), A76, 2004 | | 2004 |
| 17: Catheter-based interventions for treatment of acute coronary syndromes PL L'Allier, SG Ellis, EJ Topol Challenges in Acute Coronary Syndromes, 269, 2001 | | 2001 |
| 2016 TERMIS-Americas Conference and Exhibition San Diego, CA December 11–14, 2016 C Happe, D Deacon, R Erbe, K Tenerelli, V Tran, E Adler, N Chi, A Engler, ... Tissue Engineering Part A 22 (S1), S-1-S-156, 2016 | | 2016 |
| 23andMe CEO on Her Mission to Shake Up Preventive Care EJ Topol, AE Wojcicki | | 2014 |
| 26. The United States thrombolysis and angioplasty trials for acute myocardial JM SUTTON, EJ TOPOL PTCA An Investigational Tool and a Non-Operative Treatment of Acute Ischemia …, 2012 | | 2012 |
| 28th Bethesda Conference. Task Force 5: Assessment, approval, and regulation of new technology. JS Forrester, EJ Topol, JE Abele, DR Holmes Jr, DJ Skorton Journal of the American College of Cardiology 29 (6), 1171, 1997 | 6 | 1997 |
